Compounds > landomycinone
Page last updated: 2024-11-13

landomycinone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

landomycinone: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID51354812
CHEMBL ID1668765
CHEBI ID70059
SCHEMBL ID15144870
MeSH IDM0472652

Synonyms (6)

Synonym
landomycinone
chebi:70059 ,
CHEMBL1668765
SCHEMBL15144870
Q15426239
DTXSID001336400
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID568575Cytotoxicity against ER-refractory human MDA231 cells after 24 hrs by trypan blue staining2011Journal of natural products, Jan-28, Volume: 74, Issue:1
Landomycins P-W, cytotoxic angucyclines from Streptomyces cyanogenus S-136.
AID568574Cytotoxicity against ER-positive human MCF7 cells after 24 hrs by trypan blue staining2011Journal of natural products, Jan-28, Volume: 74, Issue:1
Landomycins P-W, cytotoxic angucyclines from Streptomyces cyanogenus S-136.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.43

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.43 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.37 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.43)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
tetrangulol
tetrangulol: structure in first source. tetrangulol : A member of the class of tetraphenes that is tetraphene-7,12-dione substituted by hydroxy groups at positions 1 and 8 and a methyl group at position 3.		2.0610p-quinones;
phenols;
tetraphenes		bacterial metabolite
urdamycin c
urdamycin C: angucycline antibiotic from Streptomyces fradiae; MF: C33-H30-O12; structure incomplete		2.0710
naphthoquinones
Naphthoquinones: Naphthalene rings which contain two ketone moieties in any position. They can be substituted in any position except at the ketone groups.		3.2960
landomycin a
landomycin A: structure given in first source; isolated from Streptomyces sp.		7.4420oligosaccharidemetabolite
landomycin d
landomycin D: structure in first source		2.0610anthraquinonemetabolite
landomycin e
landomycin E: structure given in first source; isolated from Streptomyces sp.		7.0210oligosaccharide
ConditionIndicatedRelationship StrengthStudiesTrials